Literature DB >> 3274867

Successful sequential liver-kidney transplantation in a patient with performed lymphocytotoxic antibodies.

J Fung1, M Griffin, R Duquesnoy, B Shaw, T Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3274867      PMCID： PMC2917335     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  TECHNIQUE OF RENAL HOMOTRANSPLANTATION. EXPERIENCE WITH 42 CASES.

Authors:  T E STARZL; T L MARCHIORO; T C DICKINSON; D RIFKIND; O G STONINGTON; W R WADDELL
Journal:  Arch Surg       Date:  1964-07

2.  Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells.

Authors:  F Kissmeyer-Nielsen; S Olsen; V P Petersen; O Fjeldborg
Journal:  Lancet       Date:  1966-09-24       Impact factor: 79.321

3.  Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients.

Authors:  K M Simpson; D L Bunch; H Amemiya; H J Boehmig; C B Wilson; F J Dixon; A J Coburg; W E Hathaway; G R Giles; T E Starzl
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

4.  Refinements in the surgical technique of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; C O Esquivel; S Todo; I Kam; S Lynch; R D Gordon; B W Shaw
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

5.  Reversal of transplantation immunity by liver grafting.

Authors:  N Kamada; H S Davies; B Roser
Journal:  Nature       Date:  1981-08-27       Impact factor: 49.962

6.  Successful liver transplantation from crossmatch-positive donors.

Authors:  S Iwatsuki; Y Iwaki; T Kano; G Klintmalm; L J Koep; R Weil; T E Starzl
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

7.  Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.

Authors:  J J Fung; A J Demetris; K A Porter; S Iwatsuki; R D Gordon; C O Esquivel; R Jaffe; A Tzakis; B W Shaw; T E Starzl
Journal:  Nephron       Date:  1987       Impact factor: 2.847
  7 in total
  8 in total

1.  The Denver-Pittsburgh liver transplant series.

Authors:  R D Gordon; S Iwatsuki; A G Tzakis; C O Esquivel; S Todo; L Makowka; T E Starzl
Journal:  Clin Transpl       Date:  1987

2.  HLA histocompatibility and liver transplant survival.

Authors:  B H Markus; J J Fung; R D Gordon; M Vanek; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

3.  Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?

Authors:  B H Markus; R J Duquesnoy; R D Gordon; J J Fung; M Vanek; G Klintmalm; C Bryan; D Van Thiel; T E Starzl
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

4.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

5.  ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS.

Authors:  Bernd H Markus; A Jake Demetris; Susan Saidman; John J Fung; Adriana Zeevi; Thomas E Starzl; Rene J Duquesnoy
Journal:  Clin Transplant       Date:  1988       Impact factor: 2.863

6.  Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury.

Authors:  S Kakizoe; K Yanaga; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1990-06       Impact factor: 17.425

7.  Kidney transplantation in Pittsburgh: experience and innovations.

Authors:  B H Markus; T R Hakala; A Tzakis; S Mitchell; I R Marino; R D Gordon; R J Duquesnoy; T E Starzl
Journal:  Clin Transpl       Date:  1987

8.  Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance.

Authors:  R Mañez; R H Kelly; M Kobayashi; S Takaya; O Bronsther; D Kramer; R J Duquesnoy; Y Iwaki; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.